The crystal and molecular structures of a new crystalline modification of the mesogenic PCH8 and of two solid modifications of PCH9 are described: PCH8B: Triclinic, space group P1, a = 6.369 (2), b = 11.907 (3). c = 13.119 (3) Å, α = 77.39 (1), β = 78.48 (1), γ = 77.68 (a)[ddot]; Z = 2; PCH9A: Monoclinic, space group P21/c, a = 21.562 (4), b = 5.158 (1), c = 19.326 (4) Å, β = 112.99 (1)[ddot], Z = 4; PCH9B: Triclinic, space group P1, a = 7.622 (2), b = 11.372 (3), c = 23.574 (6) Å, α = 94.20 (1), β = 95.68 (1), γ = 97.01 (l)[ddot], Z = 4. PCH9A is isostructural with PCH8A (Paulus and Haase),2 showing overlapping of the cyanophenyl groups in a head to tail manner. PCH8B and PCH9B are different from the A-modification and different from each other. PCH83 shows antiparallel CN‒CN correlation interpreted as dimers of infinite stacking, for PCH9B four molecules are showing antiparallel CN-CN clustering in form of an island. In all of the described modifications the alkylcyclohexyl groups are unflexible whereas the angle between the phenyl and the cyclohexyl groups is more flexible.
No takes yet. Share an insight, caveat, or question.
Haase et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: